Fundraising Fox

Iveacare

Roseville, US · Founded 2023 · Delaware corporation · 3 known investors

IVEAcare develops neuromodulation and bioelectronics therapies, implantable medical devices aimed at treating chronic conditions for large patient populations. The company partners with physicians to advance new therapies in the treatment of unmet clinical needs.

Deep TechHealthtechMedical Devices

Founders & leadership

Iveacare was founded in 2023 by Todd Kerkow, Mudit Jain, and Lynn.

TKTodd Kerkow
Todd KerkowinCo-Founder, President and CEO
MJ
Mudit JainCo-Founder and Chairman of the Board
L
LynninCo-Founder and Board Member
CD
Corey DishmonNamed on SEC filing
RG
Robert GreenbergNamed on SEC filing

Board

KNKirk Nielsen
Kirk NielseninBoard directorCo-Founder and Managing Partner at Vensana Capital
ASAmrinder Singh
Amrinder SinghinBoard directorPartner at Vensana Capital
TP
Tracy PappasinBoard directorInvestor at Treo Ventures, Llc
DR
Doug ReedBoard director

Investors · 3

Treo Ventures, LlcMinneapolis
Hatteras Venture Partnersreported · 2 sourcesResearch Triangle · $500K – $4M
Vensana Capitalreported · 3 sourcesMinneapolis

Reported raises · per SEC filings

Form D private placements

$15.5M disclosed across 1 round · 2024

▶$15.5MraisedApr 2024 · 5 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Corey DishmonDirector
  • Todd KerkowExecutive Officer, Director
  • Mudit JainExecutive Officer, Director
  • Robert GreenbergDirector
  • Kirk NielsenDirector
  • Amrinder SinghDirector
  • Tracy PappasDirector
  • Doug ReedDirector
Offering amount
$27.6M
Amount sold
$15.5M
First sale
Apr 2024
Incorporated
Corporation, Delaware, 2023
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 1

by search overlap
IQVIA8 shared keywordsIQVIA provides data, analytics, AI, and technology-driven services for life sciences and healthcare organizations, spanning clinical development, real world evidence generation, and commercial execution. It offers integrated solutions for clinical trials, regulatory and safety compliance, and market analytics, including agentic AI products for commercial and R&D teams.

Companies competing with Iveacare for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

Roseville-based medical device company iVEAcare raises $27.5 million in Series A funding round - Minneapolis / St. Paul Business Journalbizjournals.com · Apr 2024Fueling Innovation: iVEAcare Raises $27.5M to Advance Neuromodulation Therapyswansonreed.com · Apr 2024iVEAcare Launches with $27.5 Million in Series A Funding from Leading Medtech Investors - Vensana Capitalvensanacap.com · Apr 2024Neuromod startup IVEAcare raises $27.5M, names CEOmassdevice.com · Apr 2024iVEAcare Raises $27.5M in Series A Fundingfinsmes.com · Apr 2024

Frequently asked questions

What does Iveacare do?
IVEAcare develops neuromodulation and bioelectronics therapies, implantable medical devices aimed at treating chronic conditions for large patient populations. The company partners with physicians to advance new therapies in the treatment of unmet clinical needs.
Who founded Iveacare?
Iveacare was founded by Todd Kerkow, Mudit Jain, Lynn in 2023.
Who are Iveacare's investors?
Iveacare's investors include Treo Ventures, Llc, Hatteras Venture Partners, Vensana Capital.
How much funding has Iveacare raised?
Iveacare has disclosed $15.5M raised across 1 round.
Where is Iveacare headquartered?
Iveacare is headquartered in Roseville, US.